Log In
BCIQ
Print this Print this
 

PN277

  Manage Alerts
Collapse Summary General Information
Company Proneuron Biotechnologies Inc.
DescriptionCopolymer
Molecular Target
Mechanism of ActionImmune modulation
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationStroke
Indication DetailsTreat stroke
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today